Tuesday, August 05, 2025 6:37:34 PM
Name one OTC Merck has done a deal with?? Name an OTC biotech drug that any BP did a deal with
Here's the Perplexity AI search for ANY OTC traded biotech drug company doing a deal with BP.
"No major documented deals explicitly highlight an OTC (over-the-counter) biotech drug acquisition or licensing by a major pharmaceutical company in the last decade."
Why don't you try a Google search if you want. Deals don't happen because there's a reason Biotech's are in the OTC -- fewer regulations, lighter audits, shadier managements. Just look how much shareholder cash NWBO has burned over years. Only doing finance deals with shady vulture funds. 12 years to execute a P3 trial is ridiculously long. Lousy management including a top exec from ENRON -- how's that for a red flag????
Here's the Perplexity AI search for ANY OTC traded biotech drug company doing a deal with BP.
"No major documented deals explicitly highlight an OTC (over-the-counter) biotech drug acquisition or licensing by a major pharmaceutical company in the last decade."
Why don't you try a Google search if you want. Deals don't happen because there's a reason Biotech's are in the OTC -- fewer regulations, lighter audits, shadier managements. Just look how much shareholder cash NWBO has burned over years. Only doing finance deals with shady vulture funds. 12 years to execute a P3 trial is ridiculously long. Lousy management including a top exec from ENRON -- how's that for a red flag????
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
